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Type 2 Diabetes (T2D) represents a spectrum of metabolic
disorders is genetically heterogeneous disease with multi-
ple genes located on different chromosomes contributing
to its susceptibility. Prevalence of T2D has increased shar-
ply in recent years with more than 300 million people
worldwide and 70 million in India. The application of
molecular, genomic knowledge will provide new opportu-
nities to explore the heterogeneity which patients clearly
exhibit and provide a more accurate understanding of
individual patients. Single nucleotide polymorphisms
(SNPs) represent the most profuse form of genetic varia-
tion in humans which are gaining increased popularity
and emerging as a new generation genetic markers. With
several classes of drugs available to treat T2D its clinical
response exhibits significant variation among individuals
which exerts a huge impact on healthcare system and eco-
nomic burden due to diabetes treatment. Pharmacogenetic
research which assesses the role of genetic variants can be
used in elucidating the nature of these variants on differ-
ential drug response. In the current study, we evaluated
the association of KCNJ11, TCF7L2, SLC30A8, IGF2BP2,
PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1,
FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms
with T2D and response to sulfonylurea and metformin
using PCR-RFLP, TETRA-ARMS and DNA sequencing
techniques. Study subjects were 330 T2D patients who are
on sulfonylurea (178) and metformin (152) treatment with
age and sex matched normal healthy controls of south
Indian origin. Allele frequencies, genotype and haplotype
distribution were analyzed by chi-squared test. Logistic
regression analysis was used to predict the effect of gene
variants on treatment. Gene–gene interactions were ana-
lyzed by generalized multifactor dimensionality reduction
method. Linkage disequilibrium between each pair of SNP
loci, were estimated and plotted with JLIN. We have also
performed a systematic review and Meta-Analysis of
KCNJ11 rs5219 and PPARG rs1801282 SNPs on South
Asian populations to clarify inconsistency in association
results. Our analysis showed KCNJ11 rs5215, SLC30A8
rs1326634, TCF7L2 rs7903146 were associated with sus-
ceptibility to T2D. Multivariate regression analysis showed
that TCF7L2 rs12243326 TT genotype, KCNJ11 rs5219
TT genotype were associated with response rate to sulfo-
nylurea treatment and STK11 rs741765 GG genotype,
SLC30A8 rs1326634 TT genotype were associated with
response rate to metformin treatment.
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